JPH0418026A - Testosterone 5 alpha-reductase inhibitor - Google Patents

Testosterone 5 alpha-reductase inhibitor

Info

Publication number
JPH0418026A
JPH0418026A JP2119057A JP11905790A JPH0418026A JP H0418026 A JPH0418026 A JP H0418026A JP 2119057 A JP2119057 A JP 2119057A JP 11905790 A JP11905790 A JP 11905790A JP H0418026 A JPH0418026 A JP H0418026A
Authority
JP
Japan
Prior art keywords
testosterone
hair
alpha
cosmetic
extracted solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2119057A
Other languages
Japanese (ja)
Other versions
JPH0647554B2 (en
Inventor
Tatsuro Yamamura
達郎 山村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2119057A priority Critical patent/JPH0647554B2/en
Publication of JPH0418026A publication Critical patent/JPH0418026A/en
Publication of JPH0647554B2 publication Critical patent/JPH0647554B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To obtain testosterone 5 alpha-reductase inhibitor free from side effects, applicable to cosmetic for producing and nourishing hair and for pimple, drugs, etc., containing an extract of specific herb as an active ingredient. CONSTITUTION:Dried powder of one or more herbs selected from Salvia officinalis L., Humulus lupulus L., Rosmarinus officinalis L., Hypericum erectum Thunb., Mentha piperita L., Arnica montana L. Arnica nontana L, and Thynus vulgaris L. is immersed in 99.5% or 50% ethanol in a ratio of 1g/10ml, allowed to stand for one week and then filtered to give extracted solutions. The extracted solutions have excellent inhibitory action on testosterone 5 alpha-reductase and inhibitory action of sebum formation. Consequently, each of the extracted solutions as an active ingredient is blended with a hair tonic, a hair growing agent or a hair cosmetic, a skin external preparation for treating pimple or skin cosmetic and used.

Description

【発明の詳細な説明】 〈産業上の利用分野〉 本発明は、育毛・養毛、ニキビ用の化粧料や医薬品等に
応用可能で、かつ副作用のない、テストステロン 5α
−リダクターゼ阻害剤に関する。
[Detailed Description of the Invention] <Industrial Application Field> The present invention provides testosterone 5α, which can be applied to cosmetics and pharmaceuticals for hair growth/nourishment and acne, and has no side effects.
-Relating to reductase inhibitors.

〈従来の技術〉 男性型禿頭や脱毛症、あるいはO漏、ニキビ(尋常性ざ
f)等は、男性ホルモンの過剰によるといわれている。
<Prior Art> Male pattern baldness, alopecia, O leakage, acne (acne vulgaris), etc. are said to be caused by an excess of male hormones.

特に、毛根、皮脂腺等の器官におけるこの男性ホルモン
活性の本体は、これら標的器官においてテストステロン
がテストステロン5α−リダクターゼ(TSR)によっ
て還元されて生νVする、5α−ジヒドロテストステロ
ンCD HT )であることが知られている。すなわち
、精巣や副腎で生合成され分泌されたテストステロン(
男性ホルモン)は、血流によって皮脂腺に到達し、皮I
l¥1腺細胞中のTSRによってDHTに変換される。
In particular, it is known that the main body of this androgen activity in organs such as hair roots and sebaceous glands is 5α-dihydrotestosterone (CDHT), which is produced by reducing testosterone to νV by testosterone 5α-reductase (TSR) in these target organs. It is being In other words, testosterone (
Male hormones) reach the sebaceous glands through the bloodstream and
Converted to DHT by TSR in l\1 gland cells.

このD HTは細胞内の受容体と結合し、核に作用して
皮脂腺細胞の増殖を促す一方1毛母細胞にも作用してそ
の細胞分裂を抑制し、毛の成長を妨げるものとされてい
る。
This DHT binds to intracellular receptors and acts on the nucleus to promote the proliferation of sebaceous gland cells, while also acting on hair matrix cells to suppress their cell division and impede hair growth. There is.

従来、男性型禿頭や脱毛症またはニキビ等の治療には、
エストラジオール等の女性ホルモン作用を有する物質や
、酢酸シブロチロン等の抗男性ホルモン作用を有する物
質5強い酸化力を有する物質(ClO2等)が用いられ
ていた。また、上記のテストステロンの作用機序に着目
し、TSR活性を阻害する物質の研究も進められている
Traditionally, treatments for male pattern baldness, alopecia, acne, etc.
Substances with female hormone effects, such as estradiol, and substances with anti-androgen effects, such as cybrothyrone acetate5, have been used.5 Substances with strong oxidizing power (such as ClO2) have been used. Furthermore, focusing on the above-mentioned mechanism of action of testosterone, research on substances that inhibit TSR activity is also progressing.

〈発明が解決しようとする11g> しかし、ホルモン剤や酸化剤は副作用や安全性の面で問
題があり、化粧料への配合が不可能なものや、医師の管
理下でのみ使用が可能なものばかりであった、 また、TSR活性を阻害する物質として報告されている
ものも、その作用・効果が不十分であったり、安全性が
十分でなかったり、あるいはコスト的に高価であったり
と、種々の問題が存在するわく課題を解決するための手
段〉 我々は長年にわたり、副作用や安全性の面で問題がなく
、化粧料等に配合の可能な薬草抽出物のスクリーニング
を行ってきた。そして上記の課題についても、特定の薬
草抽出物の応用が有効であることを見い出した。
<11g that the invention seeks to solve> However, hormones and oxidizing agents have problems in terms of side effects and safety, and they cannot be incorporated into cosmetics or can only be used under the supervision of a doctor. In addition, the substances that have been reported to inhibit TSR activity may not have sufficient action or efficacy, may not be safe enough, or may be expensive. For many years, we have been screening medicinal herbal extracts that have no side effects or safety issues and can be incorporated into cosmetics. We have also found that the application of specific medicinal herbal extracts is effective in solving the above problems.

すなわち、薬草のri燥粉末を99,5%または50″
Lエタノールに1g八へmlの割合で各々浸漬し、1週
間静置した後ろ過し、ろ液を分離してTSR活性を訓べ
た、その結果、セージ(Salvia officin
alisL、)、ホップ (Hu tIlu 1 u 
s 4 L 、 )、ローズマリー(Rosmarin
us officinalis し、)、オトギリソウ
(ijz: erectum Thunj、)、ノ\ツ
カ(10−tha 紅■旦9L、) 、  カミツレ(
Matricariachど蛋用り、)、アルニカ(^
−…μ卯nta。! L、) 。
i.e. 99,5% or 50″ of medicinal herbal ri powder
They were immersed in L ethanol at a ratio of 1 g to 8 ml, allowed to stand for one week, filtered, and the filtrate was separated to study TSR activity. As a result, sage (Salvia officin)
alisL, ), hop (Hu tIlu 1 u
s 4 L, ), Rosemary (Rosmarin)
us officinalis (), Hypericum perforatum (ijz: erectum Thunj,), Not\Tsuka (10-tha), Chamomile (
Matricariach for dogs,), Arnica (^
-...μu nta. ! L.).

タイム(辻■胚腹1■nL、)の各エタノール抽出物が
有効であることを見い出した。
It was found that ethanol extracts of thyme (Tsuji 1 nL) were effective.

〈作用〉 表1に上記薬草抽出物のTSR活性活性阻害薬びタンパ
ク変性率を示す。
<Effect> Table 1 shows the TSR activity inhibition and protein denaturation rates of the above medicinal herb extracts.

TSR液として、ラット肝臓のホモジネートの9 、0
00x g上清(S−9)を用いた。まず、テストステ
ロン 3μmをプロピレングリコール10滴に溶解し、
  Tris−HC1緩衝液(pH7,2) 5 ml
を加える。これに、〜ADP)l 5mg、  S −
91ml、 Mび薬草抽出物0.5r+1を加え、37
℃で30分間インキュベートした後、ジクロロメタン5
0m1を加えて反応を停止させ、ジクロロメタン層を分
取し減圧乾燥した後、ガスクロマトグラフィー(GC)
にて反応生成物であるDHT、アントロスタンジオール
等を検出定量した(GC条件:カラム; ULBON 
HR−1,キャリアーガス; He 20m1/l1l
in、カラム温度;200℃)、、TSR活性活性阻害
薬草抽出物無添加時(コントロール)の反応生成物量と
、薬草抽出物添加時の反応生成物量の比較により求めた
9,0 of rat liver homogenate as TSR solution.
00xg supernatant (S-9) was used. First, dissolve 3 μm of testosterone in 10 drops of propylene glycol.
Tris-HC1 buffer (pH 7,2) 5 ml
Add. To this, ~ADP)l 5mg, S-
91ml, add 0.5r+1 of Mibi herbal extract, 37ml
After incubation for 30 min at °C, dichloromethane 5
0ml was added to stop the reaction, the dichloromethane layer was separated and dried under reduced pressure, and then subjected to gas chromatography (GC).
The reaction products DHT, anthrostanediol, etc. were detected and quantified (GC conditions: column; ULBON
HR-1, carrier gas; He 20ml/l1l
in, column temperature: 200°C), by comparing the amount of the reaction product when the TSR activity-inhibiting herbal extract was not added (control) and the amount of the reaction product when the herbal extract was added.

一方、タンパク変性率は、0.02%卵白アルブミンを
含む0.15M硫酸ナトリウム/ 0.05Mリン酸緩
衝液(pH7,0) 9 mlに薬草抽出物1mlを加
え、5分間攪拌した後、メンブランフィルタ−でろ過し
、高速液体クロマトグラフィー(カラム: TSK−g
el G−30005W)でアルブミンを定量して求め
た。
On the other hand, the protein denaturation rate was determined by adding 1 ml of medicinal herbal extract to 9 ml of 0.15 M sodium sulfate/0.05 M phosphate buffer (pH 7.0) containing 0.02% ovalbumin, stirring for 5 minutes, and then removing the membrane. Filter with a filter and perform high performance liquid chromatography (column: TSK-g
el G-30005W).

No、1〜8の各薬草抽出物については、99.5%あ
るいは50χエタノールのいずれの抽出物も高いTSR
S性活性阻害率した。これらのタンパク変性率は、ロー
ズマリー(No、3)の99.5%エタノール抽出物及
びオトギリソウ(No、4)の50%エタノール抽出物
において若干高い値を示したものの、概ね低い値であっ
た。従って、これら薬草抽出物は高いTSR活性阻害作
用を示し、かつこの作用は酵素タンパク質の変性による
ものではなかった。
For each herbal extract No. 1 to 8, either the 99.5% or 50χ ethanol extract has a high TSR.
S activity inhibition rate was calculated. Although these protein denaturation rates were slightly higher in the 99.5% ethanol extract of rosemary (No. 3) and the 50% ethanol extract of Hypericum perforatum (No. 4), they were generally low values. . Therefore, these medicinal herb extracts exhibited a high TSR activity inhibiting effect, and this effect was not due to denaturation of the enzyme protein.

No、9のリンデン抽出物はTSRS性活性阻害率いも
のの、タンパク変性率も92.21%と大きく、酵素タ
ンパク質の変性による阻害作用を有すると思われ、我々
の目的には好ましくない。
Although linden extract No. 9 has a high inhibition rate of TSRS activity, the protein denaturation rate is as high as 92.21%, and it seems to have an inhibitory effect due to denaturation of enzyme protein, which is not preferable for our purposes.

No、  1(1−15の各薬草抽出物については、有
意なTSR活性阻害作用は認められなかった。
No significant TSR activity inhibition effect was observed for each herbal extract No. 1 (1-15).

なお、この測定系においてエタノールの影響は認められ
なかった。
Note that no influence of ethanol was observed in this measurement system.

さらに、上記8種の薬草抽出物中には、皮脂腺の+Il
I質生合成を抑制する作用を示すものが存在する。すな
わち、10週令のゴールデンノ1ムスターの耳介皮膚の
器官培養において、FiI質生合成の阻害がHめられた
。器官培養はハム入ター耳介皮膚片(6mmφ)より内
側皮膚を剥離して軟骨を除去した後、 [!4C]−酢
酸ナトリウム4.4μCiと試料液20μ】を添加した
培養液(10%FMS含有Eagle MEM培地にペ
ニシリン、ストレプトマイシン、ファンギゾン、L−グ
ルタミンを添加したもの)2mlに表皮側が上になるよ
うに浮かせて、37℃で6時間行った。対照としてもう
一方の耳介皮膚を、試料液の代わりに溶媒のみを添加し
た培養液で培養した。
Furthermore, the above eight medicinal herbal extracts contain +Il of sebaceous glands.
There are some substances that exhibit the effect of suppressing I biosynthesis. That is, in organ culture of the auricular skin of 10-week-old golden gnomes, inhibition of FiI biosynthesis was observed. For organ culture, after exfoliating the inner skin and removing the cartilage from a piece of Ham's ear skin (6 mm diameter), [! 4C] - 4.4 μCi of sodium acetate and 20 μC of sample solution] were added to 2 ml of culture solution (Eagle MEM medium containing 10% FMS with penicillin, streptomycin, fungizone, and L-glutamine added) so that the epidermis side was facing up. It was floated at 37°C for 6 hours. As a control, the other auricular skin was cultured in a culture solution to which only a solvent was added instead of the sample solution.

培養後、生理食塩水で洗浄し、2NNaBr液に入れて
37℃で1時間静置した後、真皮と表皮を分離し、得ら
れた真皮シートをクロロホルム:メタノール(2:l)
2mlに入れ、  12時間0質の抽出を行った、脂質
生合成の阻害率は、 [!4C]−酢酸ナトIJウムの
取り込み阻害率として求め、結果を第1図に示した。
After culturing, the dermis was washed with physiological saline, placed in 2N NaBr solution, and allowed to stand at 37°C for 1 hour. The dermis and epidermis were separated, and the resulting dermal sheet was placed in chloroform:methanol (2:l)
The inhibition rate of lipid biosynthesis was extracted in 2 ml for 12 hours. The inhibition rate of uptake of 4C]-sodium acetate was determined and the results are shown in FIG.

ホップ(Hul!1ulus 7 L、)抽出液及びロ
ーズマリー(Rosmarinus officina
lis L、)抽出液においで顕著な取り込み抑制が認
められた。これらの抑制率は各々46.21%及び19
.89%であり、一般に脂質生合成を抑制するといわれ
るビタミンである塩酸ピリドキシンよりも高い抑制率を
示した。
Hop (Hul!1ulus 7 L) extract and rosemary (Rosmarinus officina)
lis L.), remarkable inhibition of uptake was observed in the extract. These inhibition rates were 46.21% and 19%, respectively.
.. The inhibition rate was 89%, which was higher than that of pyridoxine hydrochloride, a vitamin that is generally said to inhibit lipid biosynthesis.

この脂質生合成抑制作用は、TSR活性阻害を介する可
能性が高い。
This inhibitory effect on lipid biosynthesis is likely to be mediated by inhibition of TSR activity.

また、一般に、培養系における[“4Clラベル物質取
り込みによる生合成実験では、ホルモン作用による生合
成の促進、抑制は培養後12時間以上経過しないと出現
しないことが知られている(v。
In addition, it is generally known that in biosynthesis experiments using 4Cl-labeled substance incorporation in culture systems, the promotion or inhibition of biosynthesis due to hormonal action does not appear until 12 hours or more have passed after culture (v.

Wheatly  and  J、  Br1nd  
;  J、  Invest、  Der+natol
Wheatly and J, Br1nd
; J, Invest, Der+natol
.

76293−296.1981)。従って、上記の作用
はホルモン作用を介するものではなく1重篤な副作用の
生ずる心配がない、 く効果〉 以上のように、セージ(Salvia officin
alisL、3 、  ホップ (f(umulus 
□ L、) 、  ローズマリー(Rosmarinu
s officinalis L、)、  オトギリソ
ウ(L田七」erectu+n Thunb、)、ハツ
カ(Ros−tha pj2erjja L、)、カミ
ツレ(F+atricaria値ζF−9吋11旦り、
)、アルニカ(^unjcaユ律ユL、)、タイム(■
□hx=u≦7 L 、 )のエタノール抽出物は、T
SR阻害作用及び皮脂生成抑制作用を示す5 従って、
これらより1種または2種以上を選択してTSR阻害剤
として、養毛・育毛剤あるいは毛髪用化粧料、またはニ
キビ治療用皮膚外用剤や皮膚化粧料に配合することがで
きる。その際、上記作用がタンパク変性作用やホルモン
作用によるものではないので、皮膚に対するll’1l
ltや副作用のない安全な化粧料等を提供することがで
きる。
76293-296.1981). Therefore, the above-mentioned effects are not mediated by hormonal effects, and there is no need to worry about serious side effects.
alisL, 3, hop (f(umulus
□ L, ), Rosemary (Rosmarinu)
s officinalis L,), Hypericum perforatum (Ltanachi"erectu+n Thunb,), Ros-tha pj2erjja L,), Chamomile (F+atricaria value ζF-9 x 11 d),
), arnica (^unjca yuritsuyu L,), thyme (■
The ethanol extract of □hx=u≦7L, ) is T
5 showing SR inhibiting effect and sebum production suppressing effect, therefore,
One or more of these can be selected as a TSR inhibitor and incorporated into hair nourishing/growth agents or hair cosmetics, or external skin preparations for treating acne or skin cosmetics. At that time, since the above effects are not due to protein denaturation or hormonal effects,
It is possible to provide safe cosmetics and the like that are free from LT and side effects.

【図面の簡単な説明】[Brief explanation of drawings]

I!1図は脂質生合成の阻害率を表すj!4C]−酢酸
ナトリウムの取り込み阻害を示す図である。 特許出願人  株式会社 ノエビア
I! Figure 1 shows the inhibition rate of lipid biosynthesis. 4C]-sodium acetate uptake inhibition. Patent applicant Noevir Co., Ltd.

Claims (1)

【特許請求の範囲】[Claims] セージ(¥Salvia¥¥officinalis¥
L.)、ホップ(¥Humulus¥¥lupulus
¥L.)、ローズマリー(¥Ros¥−¥marinu
s¥¥officinalis¥L.)、オトギリソウ
(¥Hy¥−¥pericum¥¥erectum¥¥
Thunb¥.)、ハッカ(¥Menthapiper
ita¥L.)、カミツレ(¥Matricaria¥
¥chamomi−lla¥L.)、アルニカ(¥Ar
nica¥¥montana¥L.)、タイム(¥Th
ymus¥¥vulgaris¥L.)のエタノール抽
出物より選択した、1種または2種以上よりなるテスト
ステロン5α−リダクターゼ阻害剤。
Sage (¥Salvia¥¥officinalis¥
L. ), hops (¥Humulus¥¥lupulus
¥L. ), rosemary (¥Ros¥-¥marinu
s¥¥officinalis¥L. ), Hypericum perforatum (\Hy\-\pericum\\erectum\\
Thunb¥. ), Menthapiper
ita¥L. ), chamomile (¥Matricaria¥
¥chamomi-lla¥L. ), arnica (¥Ar
nica¥¥montana¥L. ), Time (\Th
ymus¥¥vulgaris¥L. ) A testosterone 5α-reductase inhibitor consisting of one or more kinds selected from the ethanol extracts of.
JP2119057A 1990-05-09 1990-05-09 Testosterone 5α-reductase inhibitor Expired - Fee Related JPH0647554B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2119057A JPH0647554B2 (en) 1990-05-09 1990-05-09 Testosterone 5α-reductase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2119057A JPH0647554B2 (en) 1990-05-09 1990-05-09 Testosterone 5α-reductase inhibitor

Publications (2)

Publication Number Publication Date
JPH0418026A true JPH0418026A (en) 1992-01-22
JPH0647554B2 JPH0647554B2 (en) 1994-06-22

Family

ID=14751840

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2119057A Expired - Fee Related JPH0647554B2 (en) 1990-05-09 1990-05-09 Testosterone 5α-reductase inhibitor

Country Status (1)

Country Link
JP (1) JPH0647554B2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0873324A (en) * 1994-09-06 1996-03-19 Kao Corp Hair-tonic and hair-growing agent
WO1996039157A1 (en) * 1994-11-08 1996-12-12 Taisho Pharmaceutical Co., Ltd. TESTOSTERONE 5α-REDUCTASE INHIBITOR
EP1023889A1 (en) * 1999-01-29 2000-08-02 Revlon Consumer Products Corporation A hair lotion for preventing hair loss comprising extracts of hop, rosemary and Swertia, further containing silanodiol salicylate
ES2157850A1 (en) * 1999-12-28 2001-08-16 Perdigon Jose Diaz Natural capillary hair growth stimulator consists of e.g. arnica, white nettle and juniper extracts with incorporated alcohol and water
CN1076380C (en) * 1995-01-13 2001-12-19 金坚敏 Efficient natural antioxidants and their preparation
WO2002076410A3 (en) * 2001-03-23 2003-09-25 Beiersdorf Ag Cosmetic and dermatological preparations comprising a content of a hop extract or hop-malt extract
US6638523B1 (en) 1999-10-27 2003-10-28 Nagase & Company, Ltd. Method of treating ulcers
JP2006219407A (en) * 2005-02-09 2006-08-24 Maruzen Pharmaceut Co Ltd Hair papilla cell proliferation promoter and hair tonic
JP2015020949A (en) * 2013-07-16 2015-02-02 日華化学株式会社 HAIR COSMETIC AND SKIN COSMETIC CONTAINING PGD2 PRODUCTION INHIBITOR AND 5α-REDUCTASE ACTIVITY INHIBITOR
JP2016006021A (en) * 2014-06-20 2016-01-14 株式会社ノエビア Thioredoxin-related factor expression promoter
CN118557489A (en) * 2024-07-31 2024-08-30 霸王(广州)有限公司 Antibacterial oil control composition and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4858114A (en) * 1971-11-25 1973-08-15
JPS60146829A (en) * 1984-01-05 1985-08-02 Rooto Seiyaku Kk Testosterone 5alpha-reductase inhibitor
JPH0248516A (en) * 1988-08-11 1990-02-19 Shiseido Co Ltd Hair tonic
JPH03188013A (en) * 1989-12-15 1991-08-16 Shiseido Co Ltd Testosterone-5alpha-reductase inhibitor

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4858114A (en) * 1971-11-25 1973-08-15
JPS60146829A (en) * 1984-01-05 1985-08-02 Rooto Seiyaku Kk Testosterone 5alpha-reductase inhibitor
JPH0248516A (en) * 1988-08-11 1990-02-19 Shiseido Co Ltd Hair tonic
JPH03188013A (en) * 1989-12-15 1991-08-16 Shiseido Co Ltd Testosterone-5alpha-reductase inhibitor

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0873324A (en) * 1994-09-06 1996-03-19 Kao Corp Hair-tonic and hair-growing agent
WO1996039157A1 (en) * 1994-11-08 1996-12-12 Taisho Pharmaceutical Co., Ltd. TESTOSTERONE 5α-REDUCTASE INHIBITOR
CN1076380C (en) * 1995-01-13 2001-12-19 金坚敏 Efficient natural antioxidants and their preparation
EP1023889A1 (en) * 1999-01-29 2000-08-02 Revlon Consumer Products Corporation A hair lotion for preventing hair loss comprising extracts of hop, rosemary and Swertia, further containing silanodiol salicylate
ES2147538A1 (en) * 1999-01-29 2000-09-01 Revlon Consumer Prod Corp A hair lotion for preventing hair loss comprising extracts of hop, rosemary and Swertia, further containing silanodiol salicylate
US6638523B1 (en) 1999-10-27 2003-10-28 Nagase & Company, Ltd. Method of treating ulcers
ES2157850A1 (en) * 1999-12-28 2001-08-16 Perdigon Jose Diaz Natural capillary hair growth stimulator consists of e.g. arnica, white nettle and juniper extracts with incorporated alcohol and water
WO2002076410A3 (en) * 2001-03-23 2003-09-25 Beiersdorf Ag Cosmetic and dermatological preparations comprising a content of a hop extract or hop-malt extract
JP2006219407A (en) * 2005-02-09 2006-08-24 Maruzen Pharmaceut Co Ltd Hair papilla cell proliferation promoter and hair tonic
JP2015020949A (en) * 2013-07-16 2015-02-02 日華化学株式会社 HAIR COSMETIC AND SKIN COSMETIC CONTAINING PGD2 PRODUCTION INHIBITOR AND 5α-REDUCTASE ACTIVITY INHIBITOR
JP2016006021A (en) * 2014-06-20 2016-01-14 株式会社ノエビア Thioredoxin-related factor expression promoter
CN118557489A (en) * 2024-07-31 2024-08-30 霸王(广州)有限公司 Antibacterial oil control composition and preparation method and application thereof

Also Published As

Publication number Publication date
JPH0647554B2 (en) 1994-06-22

Similar Documents

Publication Publication Date Title
JP4601898B2 (en) Topical lightening composition and method of use
JPH0418026A (en) Testosterone 5 alpha-reductase inhibitor
JP3177642B2 (en) Antiandrogens
JPH01311011A (en) Melanization inhibitory drug for external use
CN105816342A (en) Composition containing obacunone and method for using obacunone in skin whitening
JP2012006853A (en) Melanin formation inhibiting agent, cosmetic agent, skin preparation for external use, quasi-drug, and anticancer drug
JP2011178770A (en) Composition inhibiting skin pigmentation and application of the same
JPH08310923A (en) Testosterone 5alpha-reductase inhibitor
Pekmezci et al. Proprietary herbal extract downregulates the gene expression of IL-1α in HaCaT Cells: Possible implications against nonscarring alopecia
KR19990018331A (en) Hair growth promoting composition
CN110613629A (en) Whitening composition and preparation method of micro-emulsion type cosmetics
KR20040040100A (en) Liposome base for trichogenousness, Cosmetic composition for trichogenousness containing the same, and Method for improving absorptance of natural ingredients for trichogenousness using the same
KR101778654B1 (en) Use of Dihydrodehydrodiisoeugenol and preparations comprising Dihydrodehydrodiisoeugenol
CN108947944A (en) A kind of application of tyrosinase inhibitor ginger florigen A in face cream, facial cleanser or whitening emulsion
JP2004352697A (en) Tyrosinase expression inhibitor
KR20180005991A (en) Composition for skin whitening comprising Wisteria floribunda extract and use thereof
CN105272912A (en) Tyrosinase inhibitor with mercaptoquinoline skeleton structure and applications thereof
CN110876702A (en) Use of red clover extract as tyrosinase inhibitor
JP2008189558A (en) TESTOSTERONE 5alpha-REDUCTASE INHIBITOR
JPH04282320A (en) Cosmetic
JP2002029979A (en) Histamine h2 receptor antagonistic agent and skin care preparation
KR101762575B1 (en) Whitening cosmetic composition comprising withanolide of Withania somnifera
JP3165832B2 (en) Antiandrogens
KR20020008268A (en) Testosterone 5 alpha-reductase inhibitors containing extracts of galla rhois
JPH0236125A (en) Testosterone 5alpha-reductase inhibitor

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080622

Year of fee payment: 14

RD05 Notification of revocation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D05

LAPS Cancellation because of no payment of annual fees